Weiner F, Schille JT, Koczan D, Wu XF, et al. Novel chemotherapeutic agent FX-9 activates NF-kappaB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line. BMC Cancer 2021;21:1088.
PMID: 34625047